NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Jan 26, 2015

Total Value ($000): $2,062,366 (100.0% shares, 0.0% debt)

Holdings (35)

TESARO INC 17.8%
Value ($000) $366,480 Shares 9,854,255 Est. Cost $32.74 Unrealized
GROUPON INC 17.7%
Value ($000) $364,869 Shares 44,172,953 Est. Cost $8.55 Unrealized
OPOWER INC 6.2%
Value ($000) $128,031 Shares 8,997,290 Est. Cost $18.85 Unrealized
CLOVIS ONCOLOGY INC 6.2%
Value ($000) $127,668 Shares 2,279,781 Est. Cost $66.98 Unrealized
PROSENSA HLDG NV 5.9%
Value ($000) $121,503 Shares 6,480,171 Est. Cost $5.63 Unrealized
ARDX ARDELYX INC 5.1%
Value ($000) $106,184 Shares 5,621,199 Est. Cost $14.46 Unrealized +60.2%
EPIZYME INC 4.7%
Value ($000) $97,176 Shares 5,149,740 Est. Cost $27.67 Unrealized
SUPN SUPERNUS PHARMACEUTICALS INC 4.3%
Value ($000) $88,395 Shares 10,650,000 Est. Cost $5.89 Unrealized +42.7%
CVENT INC 4.0%
Value ($000) $83,429 Shares 2,996,738 Est. Cost $35.17 Unrealized
GLYCOMIMETICS INC 3.0%
Value ($000) $61,741 Shares 8,575,135 Est. Cost $16.33 Unrealized
HYPERION THERAPEUTICS INC 2.8%
Value ($000) $57,221 Shares 2,384,221 Est. Cost $22.00 Unrealized
NEVRO CORP 2.6%
Value ($000) $52,974 Shares 1,369,899 Est. Cost $38.67 Unrealized
TRIVASCULAR TECHNOLOGIES INC 2.4%
Value ($000) $49,591 Shares 3,945,191 Est. Cost $15.57 Unrealized
FOLD AMICUS THERAPEUTICS INC 2.3%
Value ($000) $47,033 Shares 5,653,029 Est. Cost $3.07 Unrealized +123.3%
VITAE PHARMACEUTICALS INC 2.1%
Value ($000) $43,484 Shares 2,613,199 Est. Cost $7.63 Unrealized
TREVENA INC 1.4%
Value ($000) $28,774 Shares 4,811,691 Est. Cost $7.47 Unrealized
CARE COM INC 1.3%
Value ($000) $27,001 Shares 3,260,989 Est. Cost $8.15 Unrealized
BOINGO WIRELESS INC 1.3%
Value ($000) $26,534 Shares 3,459,460 Est. Cost $6.21 Unrealized
AEROHIVE NETWORKS INC 1.1%
Value ($000) $23,335 Shares 4,861,455 Est. Cost $8.02 Unrealized
OREXIGEN THERAPEUTICS INC 1.1%
Value ($000) $22,477 Shares 3,709,000 Est. Cost $5.13 Unrealized
LOXO ONCOLOGY INC 1.0%
Value ($000) $21,058 Shares 1,792,207 Est. Cost $11.75 Unrealized
LEXICON PHARMACEUTICALS INC 0.7%
Value ($000) $15,175 Shares 16,676,000 Est. Cost $1.79 Unrealized
ROKA BIOSCIENCE INC 0.7%
Value ($000) $14,202 Shares 3,220,433 Est. Cost $10.05 Unrealized
MILLENNIAL MEDIA INC 0.6%
Value ($000) $13,160 Shares 8,224,752 Est. Cost $8.71 Unrealized
CHANNELADVISOR CORP 0.6%
Value ($000) $12,013 Shares 556,692 Est. Cost $15.73 Unrealized
TARGACEPT INC 0.6%
Value ($000) $12,010 Shares 4,566,666 Est. Cost $4.27 Unrealized
SUNESIS PHARMACEUTICALS INC 0.6%
Value ($000) $11,881 Shares 4,659,333 Est. Cost $5.19 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.4%
Value ($000) $9,271 Shares 2,546,843 Est. Cost $3.55 Unrealized -0.9%
ZHONE TECHNOLOGIES INC 0.4%
Value ($000) $8,463 Shares 4,781,290 Est. Cost $0.80 Unrealized
RIGEL PHARMACEUTICALS INC 0.4%
Value ($000) $7,362 Shares 3,243,150 Est. Cost $3.34 Unrealized
PARATEK PHARMACEUTICALS INC 0.3%
Value ($000) $6,704 Shares 173,894 Est. Cost $38.55 Unrealized
EXEL EXELIXIS INC 0.2%
Value ($000) $3,178 Shares 2,207,000 Est. Cost $4.74 Unrealized -67.1%
ARQULE INC 0.1%
Value ($000) $3,075 Shares 2,520,316 Est. Cost $2.32 Unrealized
AGILE THERAPEUTICS INC 0.0%
Value ($000) $802 Shares 130,644 Est. Cost $6.64 Unrealized
NEUROMETRIX INC 0.0%
Value ($000) $112 Shares 57,273 Est. Cost $2.01 Unrealized